21.07.2011 • Newsunder constructionSymriseLanxess

Lanxess Expanding Krefeld Menthol Facility

Lanxess has begun the expansion of its menthol facility at its Krefeld-Uerdingen site; the company said it will double its capacity.

Completion of the project is scheduled for the first half of 2012. The company said the additional quantities of thymol, crude menthol and D,I-menthol will allow contact parnter Symrise, manufacturer of synthetic menthol and thymol, to enter into long-term supply agreements.

As part of the construction project, three large distillation columns will be erected this fall. The largest will be about 50 meters tall and it was designed by Lanxess engineers specifically for this purpose.

"A column of such dimension is special for our plant," said production manager Dr. Lutz Heuer.

Assembly of the enormous structural elements will begin once they have been delivered to their destination in Uerdingen - an operation that will require special transportation as a heavy load.

"We will use three cranes, one of which has a lifting capacity of 900 metric tons and is the largest available in Germany. It will also enable us to lift the heaviest single element, which weighs 90 metric tons," said Heuer.

 

 

Company

Logo:

LANXESS Deutschland GmbH

Kennedyplatz 1
50569 Köln
Germany

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.